A 22-amino-acid-long multibranched peptide construct (CLV) derived from the cleavage region (KIEPLGVAPTKAKRR*VVQREKR*) of the human immunodeficiency virus (HIV) type-1 envelope precursor inhibits HIV infection (Virology, 1996, 223, 406±408). We attempted to characterize its activity for Env expressed via a recombinant vaccinia virus (rVV): gp160 cleavage was delayed, but not impaired, in the presence of CLV (10 M), whereas neither Env production nor Env membrane expression was significantly altered. Through the synthesis of analogs, we concluded that the presence of a cleavage sequence was required for inhibition of syncytium formation by CLV in rVV-infected CD4 ϩ cell cultures: indeed, a single amino acid residue substitution (R*ϾS) in the cleavage sites presented by CLV abolished its activity. Other analogs allowed us to further determine the region of CLV which mediates its activity. The ability of a radiolabeled CLV analog to enter cells was also shown. Altogether, these data strongly suggest that CLV acts on Env fusogenicity at least partially through interference with gp160 processing.
INTRODUCTION
The surface glycoprotein gp120 and the transmembrane glycoprotein gp41 are cleavage products of the gp160 precursor and the components of the mature human immunodeficiency virus (HIV) type-1 envelope (Env) (Einfeld, 1996) . gp120 and gp41 are non-covalently associated at the virus surface, where they mediate HIV binding to, and membrane fusion with, CD4 ϩ cells, respectively (Moore et al., 1993; Einfeld, 1996) .
The cleavage of gp160 into gp41 and gp120 is required for activation of the HIV envelope fusion function: mutation of gp160 cleavage sites impairs membrane fusion through precursor cleavage inhibition (McCune et al., 1988; Freed et al., 1989; Bosch and Pawlita, 1990) . During its biosynthetic pathway, gp160 cleavage resultsÐlikely in a trans Golgi compartment (Pfeiffer et al., 1997) Ðfrom the action of proteases that have not been unequivocally identified: for some, furin activity is considered the candidate for Env cleavage but several works showed that subtilisin-like protein convertases also fulfill the expected criteria (Hallenberger et al., 1992 (Hallenberger et al., , 1997 Morikawa et al., 1993; Onishi et al., 1994; Decroly et al., 1994 Decroly et al., , 1996 Decroly et al., , 1997 Gu et al., 1995; Inocencio et al., 1997; Einfeld, 1996) .
Two potential conserved tryptic-like endoproteolytic cleavage sites represented by clusters of basic amino acid residues (aa) exist on gp160 (Bosch and Pawlita, 1990; Einfeld, 1996) . A first site is defined by the sequence KAKRR (aa 505±509) and the other by the sequence REKR (aa 513±516). In vitro, furin cleaves more efficiently the REKR site when compared to the KAKRR sequence (Brakch et al., 1995) . About 15% of mature recombinant and viral Env is cleaved at site 1 and does not organize in oligomers (Fenouillet and Gluckman, 1992) but it is clear that only the cleavage at site 2 leads to fusogenic gp41 species (Freed et al., 1989; Bosch and Pawlita, 1990) : it is likely that the gp41 resulting from cleavage at site 1 is not functional because the additional polar aa sequence alters gp41 fusion peptide properties. Surprisingly, it was shown that cleavage of Env can occur when no dibasic sequence is present at the cleavage site, which raises questions about the specificity of the protease that cleaves (Dubay et al., 1995) .
Various linear peptides (Callebaut et al., 1996; De Rossi et al., 1991; Neurath et al., 1992 Neurath et al., , 1995 Slepushkin et al., 1993) and synthetic multibranched peptides (SPCs) (Yahi et al., 1994; Benjouad et al., 1995; Barbouche et al., 1998a) derived from HIV Env interfere with HIV infectivity and syncytium formation in HIV-infected CD4 ϩ cell cultures. The mode of action of these peptides remains unclear but they are supposed to interfere either with Env biosynthetic events or with post-CD4-binding events. Recently, we also reported preliminary data showing that a SPC (CLV; four branches of the KIEPLGVAPTKAKRRV-VQREKR motif) derived from the sequence encompassing the cleavage region of gp160 inhibits HIV infectivity without cell toxicity (Sabatier et al., 1996) . Based on this observation and because it was described that peptidyl chloromethylketones that possess the RXKR motif interfere with gp160 cleavage and inhibit HIV infectivity (Hal-lenberger et al., 1992) , we hypothesized that CLV may alter the cell machinery involved in Env processing and hence membrane fusion and HIV infectivity.
Here, we studied whether inhibition by CLV of syncytium formation induced by Env depends on a reduced Env production, on interference with gp160 processing, or on an altered expression at the cell surface. Through the synthesis of various CLV analogs, we determined the region of CLV which was required for the inhibitory activity. The ability of an active CLV analog to enter cells was also studied.
RESULTS
The amount of Env production was not altered in the presence of CLV We previously reported (Sabatier et al., 1996) that a 10 M concentration of CLV abolishes syncytium formation mediated by rVV expressing HIV Env in CD4 ϩ cell cultures. These conditions totally impair HIV infectivity, whereas the control SPC C was inactive. Of note: (i) a 10 M concentration of CLV did not display detectable cell toxicity as assessed by proliferation assays (data not shown and Sabatier et al., 1996) , (ii) a 1 M concentration of CLV inhibited by about 70% rVV-induced syncytium formation, and (iii) a control rVV lacking HIV env failed to induce syncytium formation (data not shown).
Because CLV may act through inhibition of Env production, we examined by dot blotÐto avoid any influence of Env conformation with the labeling procedure (Fenouillet and Gluckman, 1991) Ðthe production of Env present in lysate (gp160, gp120, and gp41) and of secreted Env (gp120) 1 or 2 days postinfection. The production was not modified by the presence of CLV (10 M) (the set of experiments with BHK-21 cells is shown in Table 1 ; n ϭ 5 experiments; Env samples corresponding to each condition were produced in three independent cell cultures). The data obtained by ELISA were in agreement with those obtained by dot blot assay: 2 days postinfection, irrespective of the presence or the absence of CLV, coating with D7324 detected about 300 ng of cell-associated gp120/10 6 cells and about 2 g of secreted gp120/10 6 cells and coating with D7323 detected about 200 ng of cell-associated gp41/10 6 cells.
Membrane expression was normal in the presence of CLV One or 2 days postinfection with rVV, CEM cells producing Env in the presence or in the absence of CLV (10 M) were incubated with a pool of HIV ϩ sera to study the kinetics of Env membrane expression (Fenouillet et al., , 1997 ): cells exhibited a similar level of Env at their surface irrespective of the presence of CLV (Fig. 1) . Ab dilutions ranging from 1/50 to 1/50 000 led to similar data (not shown). Surprisingly but reproducibly (n ϭ 3), the presence of CLV slightly increased labeling.
CLV delayed the cleavage of the gp160 precursor
The gp160 cleavage into gp120 and gp41 in the presence or in the absence of CLV (10 M) was examined by pulse± chase labeling. The amount of immunopurified labeled Env was similar in all cases ( Fig. 2A ), in agreement with the data obtained by dot blot and ELISA. According to Fenouillet and Jones (1995) and Fenouillet et al. (1997) , in the absence of CLV, gp120 was detected after a 30-min chase, and mature gp120Ðthe increased MW of which reflects carbohydrate maturation (Fenouillet and Jones, 1995) Ðwas detected after a 2-h chase. Similar data were obtained when cells were incubated with SPC C (not shown). Two hours postpulse, only a very faint band of gp160 was detected: it is likely that most of the uncleaved gp160 species was significantly degraded at that time and consequently was undetectable as a 160-kDa band after ␤-mercaptoethanol elution (as observed and discussed in Earl et al., 1991; Fenouillet and Jones, 1995) . In the presence of CLV, gp160 appeared essentially uncleaved after a 30-min chase, whereas a significant cleavage was detected 2 h postpulse. High-molecular-weight gp160 was still detected at this time. The migration of the Env species as double bands has been already observed (Fenouillet et al., 1997) in our discriminating SDS±PAGE/pulse±chase analysis conditions.
To further examine the ability of Env to be processed in the presence of CLV, a Western blot analysis of Env stored either in cell supernatant or in cell lysate 2 days postinfection was performed (Fig. 2B) . The results supported the data presented in the pulse±chase study and those obtained by dot blot and ELISA as reported above: in the presence of CLV, a significant amount of cleaved gp41 and gp120 was detected into the cell pellet; after membrane expression, the gp120 subunit was efficiently secreted into the cell supernatant.
Thus, cleavage of Env was delayed, but not inhibited, in the presence of CLV.
CLV should present a functional cleavage site to be active
To determine the aa involved in CLV activity, we synthesized various analogs which were tested for their cell toxicity and ability to inhibit syncytium formation induced by rVV infection in CD4 ϩ cell cultures, as described in Sabatier et al. (1996) (Table 2 ). Irrespective of their sequence and length, these analogs presented a cytotoxicity similar to that of CLV. The L analogÐwhich presents a R 509/516 ϾS substitution in the cleavage sitesÐfailed to inhibit syncytium formation ( Table 2 ). The fact that the S analogÐit presents a REKR motif without aa sequence downstream this siteÐwas inactive indicates that the REKR sequence including the R 516 residue adjacent to the Lys core is not involved in CLV activity. In full contrast, the M analogÐwhich contains a cleavage region with aa upstream and downstream the cleavage siteÐ was as active as CLV, despite the deletion of a large part of the sequence upstream the first cleavage site. The ability of the various analogs to inhibit infection of C8166 cells by HIV MN was also examined: according to the data presented above, the L and the S analogs were found inactive (data not shown). These data indicate that CLV exhibited its anti-HIV activity through the presence of a functional cleavage sequence on the peptide construct.
CLV Y enters CEM cells
The ability of the active CLV Y analog to enter CEM cells (Fig. 3) was studied. We observed that CLV Y was able to rapidly bind cell membrane and enter cells (the CLV:
Note.
[GPGKTL] 8 -K 4 -K 2 -K-␤A is a negative SPC control; a reduction of the syncytium score by 90% (IC 90 ) relative to the negative control was considered to result from a significant inhibitory activity of the corresponding peptide. Barbouche et al. (1998b) as`cell-associated radioactivity obtained when incubation was performed in the absence of NaN 3 '' minus`cell-associated radioactivity obtained when incubation was performed in the presence of NaN 3 '').
amount of internalized CLV Y was calculated as described under Materials and Methods and in

DISCUSSION
This work is the third to report the design and the characterization of peptide compounds derived from the endoproteolytic cleavage sequence of HIV Env. One of these works showed that decanoylated peptides derived from the gp160 cleavage region failed to inhibit in cell culture gp160 cleavage. Moreover, their important cell toxicity did not allow further development as anti-HIV therapeutic agents (Decroly et al., 1994) .
In strong contrast, the pioneer work by Hallenberger et al. demonstrated that a set of peptide chloromethylketones (PCMK) which are derived from the gp160 cleavage region``interfere with Env cleavage and hence its activation'' (Hallenberger et al., 1992) . It is important to note that, in this work, the authors showed that an important cleavage of Env does exist (about 50% when Env was expressed by rVV in this study) in the presence of PCMK and that despite the expression of an important amount of cleaved Env, HIV infectivity is abolished.
We present here data which confirm and expand this latter work. Indeed, we showed that a 10 M concentration of CLVÐa peptide which encompasses a large sequence of the cleavage region of the Env precursorÐ delayed, but did not prevent, gp160 processing, whereas it fully abolished syncytium formation. This compound is more potent than the PCMKs previously described (Hallenberger et al., 1992) . The ability of a labeled CLV analog to enter cells is in agreement with such an intracellular effect. However, this interference with gp160 cleavage was not sufficient to alter substantially the amount of cleaved Env produced and expressed at the cell surface. The observed shedding into the cell supernatant of mature cleaved gp120 is another evidence that gp160 cleavage was not blocked by the treatment by CLV. Surprisingly, the presence of CLV slightly increased Env membrane expression, in agreement with the previous observation of Hallenberger et al. (1992) , who observed that PCMKs slightly decrease shedding of gp120.
Because CLV altered at least the cleavage process during biosynthesis, we hypothesized that the presence of a cleavage substrate sequence on CLV was actually responsible for its interference with membrane fusion. To address this point, we synthesized various analogs of CLV on the basis of the data obtained in a previous study based on site-directed mutagenesis, which determined the aa required for Env cleavage (Bosch and Pawlita, 1990; Einfeld, 1996) . First, we synthesized a CLV analog which presents a R Ͼ S substitution in the cleavage sites. Such a mutation on env impairs Env cleavage (Bosch and Pawlita, 1990) . Such an analog was inactive. Similarly, an analog which presents a REKR motif close to the uncharged Lys core lacked activity (The Lys core is uncharged as a result of the SPC synthesis). In full contrast, the M analog which presents a functional site 1 was active, despite the removal of several aa upstream to the functional cleavage site. From these data, we conclude that the sole presence of a functional cleavage region is responsible for CLV activity. This further argues in favor of a CLV-induced inhibition of syncytium formation through interferences with the enzymatic machinery involved in gp160 processing. Additional interferences of CLV with some steps of the membrane fusion process per se may act together with the interference with Env cleavage to completely impair membrane fusion. It is also possible that the presence of both cleaved and uncleaved Env within the same oligomers late in the intracellular routing or at the membrane disturbs the Env functions and structure to inactivate it. These hypotheses are under investigation to explain why CLV exhibits so potent an effect on Env functions despite its apparently slight effect on Env processing.
MATERIALS AND METHODS
Materials
D7324 (Aalto, Dublin, Ireland) is a polyclonal antibody (Ab) against gp120 Ct (aa 502±516); D7323 is against gp41 Ct (aa 845±860); 9305 and 9301 (DuPont de Nemours, Dreieich, Germany) are mouse monoclonal anti-gp120 Abs directed against aa 318±328 and aa 475± 486, respectively. Chemical products were of analytical ϩ lymphoid cells of a labeled active CLV analog. CEM cells were incubated at 37°C with the radiolabeled CLV Y analog. Cell-associated radioactivity when incubation was performed in the presence of NaN 3 Ða condition that impairs endocytosisÐwas considered membrane-associated CLV Y (Mb CLV). CLV Y present within the cells (Int CLV) was calculated as follows:`cell-associated radioactivity obtained when incubation was performed in the absence of NaN 3 (Tot CLV)'' minus``Mb CLV. '' grade (Sigma, St Louis, MO). Products for peptide synthesis were from Perkin±Elmer (Paris, France).
Synthesis of synthetic polymeric constructions
Chemical synthesis of SPCs was performed by the solid phase technique using Fmoc/t-butyl chemistry, as described by Yahi et al. (1994) . The crude peptides were purified to homogeneity by C18 reversed-phase mediumpressure liquid chromatography (Barbouche et al., 1998a,b) . The purity of the peptides was assessed by analytical C18 reversed-phase high-pressure liquid chromatography (Barbouche et al., 1998a,b) . Fractions containing purified peptides were pooled and characterized by both aa analysis after acid hydrolysis and mass spectrometry. They were then tested in bioassays. SPCs are as follows: SPC C (a negative control): 
Syncytium formation
Human lymphoid CD4
ϩ CEM cellsÐcultured in RPMI 1640 medium supplemented with 5% fetal calf serum (FCS) and 1% GlnÐwere infected in 12-well plates in the presence of various SPCs for 18 h with a recombinant vaccinia virus (rVV) expressing HIVLai Env (Kie Â ny et al., 1988; VV9-1; 0 .2 PFU/cell; a gift of Marie-Paule Kie Á ny, Transge Á ne, Strasbourg, F), as described by Fenouillet et al. (1993) .
Env production and quantitation
Baby hamster kidney (BHK-21) cellsÐcultured in Glasgow medium supplemented with 5% FCS and 1% GlnÐor CEM cells were infected as described above. Infections were performed in FCS-free medium to allow, after 1 or 2 days, supernatant concentration [5-fold using a 30-kDa cutoff Centriprep system (Amicon, Danvers, MA)] (Fenouillet et al., 1993) ; cell pellets were lysed in phosphate-buffered saline, pH 7.4 (PBS), 0.1% Triton X100.
The quantities of Env obtained in the different systems were determined by dot blot (described in Fenouillet and Gluckman, 1991) and ELISA (Fenouillet et al., 1993) , using as reference a cell lysate spiked with a known amount of recombinant Env (Fenouillet et al., 1992 (Fenouillet et al., , 1993 . Briefly: (i) dot blot: 5, 2.5, and 1 l of lysate (10 6 cells/10 L of lysate) or 5ϫ supernatant (10 6 cells/100 L) adjusted to 10 l final volume of PBS were blotted onto a nitrocellulose filter. Staining was performed with a pool of HIV ϩ sera (1:50) which was devoid of detectable Abs against VV (Fenouillet et al., 1993) and preincubated with CLV (3 ⅐ 10 Ϫ4 M) to inhibit a possible bias induced by the reactivity of Abs with CLV present in the samples. Under these conditions, the Abs used as described below reacted neither with uninfected cells incubated with 10 M CLV nor with the medium or cell lysate. Peroxidaselabeled anti-human IgG Abs (Dakopatts, Glostrup, Denmark) were then added (1/100). (ii) ELISA: wells (Nunc, Roskild, Denmark) were coated (200 ng/100 L) with D7324Ðto detect gp160 and gp120Ðor D7323Ðto detect gp160 and gp41. Lysates or 5ϫ supernatants were added. After washing, the pool of HIV ϩ sera was added and staining was performed as described above.
Alternatively, a Western blot analysis of Env present either in cell supernatant or in cell lysate was performed as reported by Fenouillet et al. (1996) . Briefly, concentrated (5ϫ) supernatants (50 L) and cell lysates (2 ⅐ 10 6 cells/50 L) were submitted to SDS±polyacrylamide gel electrophoresis (PAGE) under nonreducing conditions. After blotting, staining was obtained (i) with human anti-HIV-1 Abs (diluted 1/100 to detect Env species in the supernatant), (ii) with a mixture of 9305 and 9301 mAbs (diluted 1/50 to detect gp120 and gp160 in the lysates), or (iii) with D7323 (diluted 1/100 to detect gp41 and gp160 in the lysates). Incubations and washes were performed in PBS 0.5% casein, 0.5% Tween 20. Peroxydase-conjugated anti-Abs were then incubated for 1 h before staining with diaminobenzidine.
Detection of Env membrane expression
Cells were infected with rVV for 1 or 2 days. After a wash in PBS, cells were treated with 2% paraformaldehyde. After 18 h, 3 ⅐ 10 6 cells were washed in PBS 2% casein (PBSC) and incubated for 2 h with a saturating concentration (1:100) of the pool of HIV ϩ sera to detect membrane Env as described (Fenouillet et al., , 1997 . After a wash, peroxidase-coupled anti-Abs were added (1/50 in PBSC) for 1 h. After washes, chromogen was added. The labeling was specific for the membrane expression of Env, as it was dependent on the Ab concentration and as incubation with a pool of HIV Ϫ sera did not label infected cells (Fenouillet et al., 1997 , and data obtained under these conditions and not shown).
Env precursor cleavage gp160 cleavage into gp120 and gp41 was examined by pulse±chase labeling as described in Fenouillet et al. (1995 Fenouillet et al. ( , 1997 . Briefly, after starvation 15 h postinfection for 1 h, 10 7 cells were labeled for 30 mn with a [ 35 S]Met/Cys mixture (Amersham, UK; 300 mCi); Met-supplemented (100 g/mL) medium was then added for 30 or 120 min. Cells were lysed in Tris 25 mM, 300 mM NaCl, pH 7.4, 0.5% Triton X-100, and 0.25% SDS and a pool of HIV ϩ sera (1:50) was added for 3 h in the same buffer. Protein A±Sepharose (Pharmacia, Uppsala, Sweden) was then added. After washes in the lysis buffer, elution was obtained with 10% SDS, 10% ␤-mercaptoethanol before analysis by 10% SDS±PAGE (Fenouillet et al., 1997) .
Internalization of an active radiolabeled CLV analog
The active CLV Y (5 g) was labeled with 125 I-labeled Na (300 Ci) in a 4 nM iodogen-coated tube for 30 mn at 20°C (Barbouche et al., 1998a,b) . Labeled CLV Y (sp act 50 Ci/g) was purified on a PD10 column (Pharmacia). CEM cells were incubated with 125 I-labeled CLV Y in cell culture medium for various times. Triplicates were performed (n ϭ 2 experiments). For each incubation time, a triplicate was similarly incubated but the presence of 0.1% NaN 3 to avoid endocytosis as reported in Barbouche et al. (1998b) . Samples were then washed twice with PBSC, 0.1% NaN 3 and cell-associated radioactivity was counted. Cell-associated radioactivity when incubation was performed in the presence of NaN 3 represented membrane-associated CLV Y. Accordingly,
125
I-labeled CLV Y present within the cells was calculated for each time point as follows:`cell-associated radioactivity obtained when incubation was performed in the absence of NaN 3 '' minus`cell-associated radioactivity obtained when incubation was performed in the presence of NaN 3 ,'' as reported by Barbouche et al. (1998b) .
